Immunohistochemical ERG positivity is associated with decreased PSMA expression and lower visibility in corresponding [ 68 Ga]Ga-PSMA-11 PET scans of primary prostate cancer.
Autor: | Rupp NJ; Department of Pathology and Molecular Pathology, University Hospital Zurich, Schmelzbergstrasse 12, 8091, Zürich, Switzerland. niels.rupp@usz.ch.; University of Zurich, Zurich, Switzerland. niels.rupp@usz.ch., Freiberger SN; Department of Pathology and Molecular Pathology, University Hospital Zurich, Schmelzbergstrasse 12, 8091, Zürich, Switzerland.; University of Zurich, Zurich, Switzerland., Ferraro DA; Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Zurich, Switzerland.; Department of Radiology and Oncology, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, Sao Paulo, Brazil., Laudicella R; Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Zurich, Switzerland.; Department of Biomedical and Dental Sciences and Morpho-Functional Imaging, Nuclear Medicine Unit, University of Messina, Messina, Italy., Heimer J; Seminar for Statistics, Federal Institute of Technology (ETH) Zurich, Zurich, Switzerland., Muehlematter UJ; Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Zurich, Switzerland., Poyet C; Department of Urology, University Hospital Zurich, University of Zurich, Zurich, Switzerland., Moch H; Department of Pathology and Molecular Pathology, University Hospital Zurich, Schmelzbergstrasse 12, 8091, Zürich, Switzerland.; University of Zurich, Zurich, Switzerland., Eberli D; University of Zurich, Zurich, Switzerland.; Department of Urology, University Hospital Zurich, University of Zurich, Zurich, Switzerland., Rüschoff JH; Department of Pathology and Molecular Pathology, University Hospital Zurich, Schmelzbergstrasse 12, 8091, Zürich, Switzerland., Burger IA; Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Zurich, Switzerland.; Department of Nuclear Medicine, Cantonal Hospital Baden, affiliated Hospital for Research and Teaching of the Faculty of Medicine of the University of Zurich, Baden, Switzerland. |
---|---|
Jazyk: | angličtina |
Zdroj: | European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2024 Jul 31. Date of Electronic Publication: 2024 Jul 31. |
DOI: | 10.1007/s00259-024-06856-x |
Abstrakt: | Purpose: TMPRSS2:ERG gene fusion negatively regulates PSMA expression in prostate adenocarcinoma (PCa) cell lines. Therefore, immunohistochemical (IHC) ERG expression, a surrogate for an underlying ERG rearrangement, and PSMA expression patterns in radical prostatectomy (RPE) specimens of primary PCa, including corresponding PSMA-PET scans were investigated. Methods: Two cohorts of RPE samples (total n=148): In cohort #1 (n=62 patients) with available RPE and preoperative [ 68 Ga]Ga-PSMA-11 PET, WHO/ISUP grade groups, IHC-ERG (positive vs. negative) and IHC-PSMA expression (% PSMA-negative tumour area, PSMA Results: Cohort #1: PCa with IHC-ERG expression (35.5%) showed significantly lower IHC-PSMA expression and lower SUV Conclusion: IHC-ERG expression is significantly associated with more heterogeneous and lower IHC-PSMA tissue expression in two independent RPE cohorts. There is a strong association of ERG positivity in RPE tissue with lower [ 68 Ga]Ga-PSMA-11 uptake on corresponding PET scans. Results may serve as a base for future biomarker development to enable tumour-tailored, individualized imaging approaches. (© 2024. The Author(s).) |
Databáze: | MEDLINE |
Externí odkaz: |